Chemoinformaics analysis of propionic acid ester
| Molecular Weight | 186.251 | nRot | 5 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 6 |
| Exact Molecular Weight | 186.126 | nRing | 1 |
| Solubility: LogS | -1.746 | nHRing | 1 |
| Solubility: LogP | 1.465 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 31.1083 |
| nHD | 0 | BPOL | 22.3977 |
| QED | 0.486 |
| Synth | 2.613 |
| Natural Product Likeliness | 0.318 |
| NR-PPAR-gamma | 0.031 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.191 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.468 |
| MDCK | 0.0000419 |
| BBB | 0.519 |
| PPB | 0.42296 |
| VDSS | 0.927 |
| FU | 0.543946 |
| CYP1A2-inh | 0.196 |
| CYP1A2-sub | 0.461 |
| CYP2c19-inh | 0.126 |
| CYP2c19-sub | 0.67 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.147 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.189 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.268 |
| CL | 13.113 |
| T12 | 0.756 |
| hERG | 0.086 |
| Ames | 0.008 |
| ROA | 0.02 |
| SkinSen | 0.932 |
| Carcinogencity | 0.324 |
| EI | 0.832 |
| Respiratory | 0.048 |
| NR-Aromatase | 0.217 |
| Antiviral | No |
| Prediction | 0.88714 |